Search

Search Constraints

You searched for: Author/Creator Metro, Giulio

Search Results

11. Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?. Issue 163 (March 2018)

12. Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. (August 2019)

14. Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy. Issue 3 (22nd December 2021)

16. Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma. Issue 9 (2nd September 2021)

17. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab. (1st September 2020)